Sagimet Biosciences Inc. - Series A Common Stock (NQ:SGMT)
5.755
-0.325
(-5.35%)
Streaming Delayed Price
Updated: 11:46 AM EST, Feb 5, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 310,462 |
| Open | 6.080 |
| Bid (Size) | 5.750 (3,400) |
| Ask (Size) | 5.760 (100) |
| Prev. Close | 6.080 |
| Today's Range | 5.670 - 6.160 |
| 52wk Range | 1.730 - 11.41 |
| Shares Outstanding | 30,674,855 |
| Dividend Yield | N/A |
Top News
More News
Tuesday's session: gap up and gap down stocks ↗
February 03, 2026
Performance
More News
Read More
Frequently Asked Questions
Is Sagimet Biosciences Inc. - Series A Common Stock publicly traded?
Yes, Sagimet Biosciences Inc. - Series A Common Stock is publicly traded.
What exchange does Sagimet Biosciences Inc. - Series A Common Stock trade on?
Sagimet Biosciences Inc. - Series A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Sagimet Biosciences Inc. - Series A Common Stock?
The ticker symbol for Sagimet Biosciences Inc. - Series A Common Stock is SGMT on the Nasdaq Stock Market
What is the current price of Sagimet Biosciences Inc. - Series A Common Stock?
The current price of Sagimet Biosciences Inc. - Series A Common Stock is 5.755
When was Sagimet Biosciences Inc. - Series A Common Stock last traded?
The last trade of Sagimet Biosciences Inc. - Series A Common Stock was at 02/05/26 11:46 AM ET
What is the market capitalization of Sagimet Biosciences Inc. - Series A Common Stock?
The market capitalization of Sagimet Biosciences Inc. - Series A Common Stock is 176.53M
How many shares of Sagimet Biosciences Inc. - Series A Common Stock are outstanding?
Sagimet Biosciences Inc. - Series A Common Stock has 177M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.